Kimia Biosciences

Kimia Biosciences Limited aims to research and develop new, improved drugs to address unmet patient needs and build a strong portfolio of next-generation treatments. The company's fundamental mission centers around providing wellness and healthy choices for its consumers, a purpose that has remained constant despite the evolving external environment. It is committed to making significant investments in drug research and development to produce effective, safe, and affordable medicines for people worldwide. The company manufactures final product bulk drugs, also known as Active Pharmaceutical Ingredients (APIs), and markets them in overseas markets that require WHO certifications. Its research and development has forged ahead by developing innovative technologies, improving costs in existing products, and developing key raw materials in-house. To support this growth, its R&D team has expanded to more than 60 scientists and has already commercialized over 25 different products.;